STOCK TITAN

Snowflake director sells 300K shares around $330

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Snowflake Inc. (SNOW) director Frank Slootman reported exercising stock options for 300,000 shares of common stock at an exercise price of $8.88 per share on September 18 and 21, 2026, and selling 300,000 shares in multiple open-market transactions at prices around the low-to-mid $330s. These exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2025, and some additional shares are held indirectly through various trusts for which he or his spouse serves as trustee.

Positive

  • None.

Negative

  • None.
Insider Slootman Frank
Role Director
Sold 300,000 shs ($100.35M)
Approx. gross sale proceeds $100.35M
Approx. exercise cost $2.66M
Approx. pre-tax spread $97.68M
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1, F25 102,791 $0.00 $0.00
Exercise Common Stock F1, F2 102,791 $8.88 $913K
Sale Common Stock F1, F10, F2 1,936 $330.165 $639K
Sale Common Stock F1, F11, F2 2,268 $331.181 $751K
Sale Common Stock F1, F12, F2 6,671 $332.261 $2.22M
Sale Common Stock F1, F13, F2 5,740 $333.465 $1.91M
Sale Common Stock F1, F14, F2 25,159 $334.349 $8.41M
Sale Common Stock F1, F15, F2 25,268 $335.081 $8.47M
Sale Common Stock F1, F16, F2 9,843 $336.293 $3.31M
Sale Common Stock F1, F17, F2 15,867 $337.237 $5.35M
Sale Common Stock F1, F18, F2 7,529 $338.121 $2.55M
Sale Common Stock F1, F19, F2 2,510 $338.994 $851K
Exercise Stock Option (Right to Buy) F1, F25 197,209 $0.00 $0.00
Exercise Common Stock F1, F2 197,209 $8.88 $1.75M
Sale Common Stock F1, F3, F2 15,187 $331.352 $5.03M
Sale Common Stock F1, F4, F2 23,507 $332.189 $7.81M
Sale Common Stock F1, F5, F2 79,366 $333.269 $26.45M
Sale Common Stock F1, F6, F2 42,009 $334.24 $14.04M
Sale Common Stock F1, F7, F2 2,841 $335.228 $952K
Sale Common Stock F1, F8, F2 4,097 $336.107 $1.38M
Sale Common Stock F1, F2 102 $337.05 $34K
Sale Common Stock F1, F9, F2 30,100 $338.609 $10.19M
holding Common Stock F20 -- -- --
holding Common Stock F21 -- -- --
holding Common Stock F22 -- -- --
holding Common Stock F23 -- -- --
holding Common Stock F24 -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 4,136,655 contracts (Direct); Common Stock — 19,024 shares (Direct); Common Stock — 210,029 shares (Indirect, Trust)
Footnotes (25)
  1. F1. The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
  2. F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
  3. F3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.745 to $331.740, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
  4. F4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.760 to $332.750, inclusive.
  5. F5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.770 to $333.760, inclusive.
  6. F6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.780 to $334.775, inclusive.
  7. F7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.785 to $335.770, inclusive.
  8. F8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.800 to $336.480, inclusive.
  9. F9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.250 to $338.610, inclusive.
  10. F10. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $329.540 to $330.510, inclusive.
  11. F11. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.705 to $331.520, inclusive.
  12. F12. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.730 to $332.725, inclusive.
  13. F13. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.750 to $333.740, inclusive.
  14. F14. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.750 to $334.745, inclusive.
  15. F15. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.750 to $335.740, inclusive.
  16. F16. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.765 to $336.750, inclusive.
  17. F17. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $336.780 to $337.750, inclusive.
  18. F18. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $337.780 to $338.720, inclusive.
  19. F19. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.800 to $339.340, inclusive.
  20. F20. The shares are held by the Slootman Living Trust dated 9/8/1999 for which the Reporting Person is a trustee.
  21. F21. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
  22. F22. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
  23. F23. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
  24. F24. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
  25. F25. The stock option is fully vested.
Options exercised 300,000 shares Stock options for Snowflake common stock exercised on September 18 and 21, 2026
Exercise price $8.88 per share Exercise price of stock options converted into Snowflake common stock
Shares sold 300,000 shares Total Snowflake common shares sold in open-market transactions reported in this Form 4
Sample sale price $331.352 per share Weighted-average price for a 15,187-share sale on September 18, 2026
Highest reported sale price example $338.609 per share Weighted-average price for a 30,100-share sale on September 18, 2026
Rule 10b5-1 plan adoption date September 19, 2025 Date the trading plan governing these exercises and sales was adopted
Option expiration date May 28, 2029 Expiration date for the fully vested stock options that were exercised
Rule 10b5-1 trading plan regulatory
"The exercises and sales reported ... were effected pursuant to a 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted-average price financial
"The price reported in Column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
restricted stock units financial
"Includes shares to be issued in connection with the vesting of one or more restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Grantor Retained Annuity Trust financial
"The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
Living Trust financial
"The shares are held by the Slootman Living Trust dated 9/8/1999"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Snowflake (SNOW) director Frank Slootman report in this Form 4?

He reported exercising options for 300,000 SNOW shares at $8.88 per share and selling 300,000 shares of common stock in multiple open-market transactions in the low-to-mid $330s on September 18 and 21, 2026, under a Rule 10b5-1 trading plan.

How many Snowflake (SNOW) shares did Frank Slootman sell and at what prices?

He sold a total of 300,000 SNOW shares in multiple blocks at weighted-average prices generally between the low $330s and high $330s, including specific reported prices such as $331.352, $333.269, $334.240, and $338.609 per share.

What stock options did Frank Slootman exercise in Snowflake (SNOW)?

He exercised stock options covering 300,000 shares of Snowflake common stock at an exercise price of $8.88 per share. The options are described as fully vested and carry an expiration date of May 28, 2029 in the option-related entries.

Were Frank Slootman’s SNOW transactions made under a Rule 10b5-1 plan?

Yes. A footnote states that the exercises and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by Frank Slootman on September 19, 2025, and the filing indicates the Rule 10b5-1 checkbox as affirmed.

Does Frank Slootman hold any Snowflake (SNOW) shares indirectly?

Yes. Footnotes state that certain shares are held by several trusts, including the Slootman Living Trust, Slootman Grandchildren's Trust, Slootman 2023 Children's Trust, and two Grantor Retained Annuity Trusts, where he or his spouse serves as trustee.

What are the key dates of the Snowflake (SNOW) insider transactions?

The reported option exercises and related sales occurred on September 18, 2026 and September 21, 2026. The Rule 10b5-1 trading plan under which these were effected was adopted on September 19, 2025, and the option expiration date is May 28, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Slootman Frank

(Last)(First)(Middle)
C/O SNOWFLAKE INC.
135 CONSTITUTION DRIVE

(Street)
MENLO PARK CALIFORNIA 94025

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Snowflake Inc. [ SNOW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/18/2026M(1)197,209A$8.88216,233(2)D
Common Stock09/18/2026S(1)15,187D$331.352(3)201,046(2)D
Common Stock09/18/2026S(1)23,507D$332.189(4)177,539(2)D
Common Stock09/18/2026S(1)79,366D$333.269(5)98,173(2)D
Common Stock09/18/2026S(1)42,009D$334.24(6)56,164(2)D
Common Stock09/18/2026S(1)2,841D$335.228(7)53,323(2)D
Common Stock09/18/2026S(1)4,097D$336.107(8)49,226(2)D
Common Stock09/18/2026S(1)102D$337.0549,124(2)D
Common Stock09/18/2026S(1)30,100D$338.609(9)19,024(2)D
Common Stock09/21/2026M(1)102,791A$8.88121,815(2)D
Common Stock09/21/2026S(1)1,936D$330.165(10)119,879(2)D
Common Stock09/21/2026S(1)2,268D$331.181(11)117,611(2)D
Common Stock09/21/2026S(1)6,671D$332.261(12)110,940(2)D
Common Stock09/21/2026S(1)5,740D$333.465(13)105,200(2)D
Common Stock09/21/2026S(1)25,159D$334.349(14)80,041(2)D
Common Stock09/21/2026S(1)25,268D$335.081(15)54,773(2)D
Common Stock09/21/2026S(1)9,843D$336.293(16)44,930(2)D
Common Stock09/21/2026S(1)15,867D$337.237(17)29,063(2)D
Common Stock09/21/2026S(1)7,529D$338.121(18)21,534(2)D
Common Stock09/21/2026S(1)2,510D$338.994(19)19,024(2)D
Common Stock2,174ITrust(20)
Common Stock16,300ITrust(21)
Common Stock78,893ITrust(22)
Common Stock56,331ITrust(23)
Common Stock56,331ITrust(24)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$8.8809/18/2026M(1)197,209 (25)05/28/2029Common Stock197,209$04,239,446D
Stock Option (Right to Buy)$8.8809/21/2026M(1)102,791 (25)05/28/2029Common Stock102,791$04,136,655D
Explanation of Responses:
1. The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.745 to $331.740, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.760 to $332.750, inclusive.
5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.770 to $333.760, inclusive.
6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.780 to $334.775, inclusive.
7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.785 to $335.770, inclusive.
8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.800 to $336.480, inclusive.
9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.250 to $338.610, inclusive.
10. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $329.540 to $330.510, inclusive.
11. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.705 to $331.520, inclusive.
12. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.730 to $332.725, inclusive.
13. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.750 to $333.740, inclusive.
14. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.750 to $334.745, inclusive.
15. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.750 to $335.740, inclusive.
16. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.765 to $336.750, inclusive.
17. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $336.780 to $337.750, inclusive.
18. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $337.780 to $338.720, inclusive.
19. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.800 to $339.340, inclusive.
20. The shares are held by the Slootman Living Trust dated 9/8/1999 for which the Reporting Person is a trustee.
21. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
22. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
23. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
24. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
25. The stock option is fully vested.
Remarks:
/s/ Marie Reider, Attorney-in-Fact09/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading